Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials.
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
New findings suggest that a person’s own immune system helps nudge him or her down the path toward Parkinson’s, and that restraining the immune system with drugs potentially could prevent the neurological disorder.
In a new multicenter clinical trial, a personalised vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma.
New research may explain the link between a high level of iron in the body and prostate cancer.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Starting about 7,000 years ago, and extending over the next two millennia, recent studies suggest, the genetic diversity of men—specifically, the diversity of their Y chromosomes—collapsed.
The Norwegian Academy of Science and Letters, which is one of the world’s richest science awards in the world, have announced its award will go to three discoverers of the genome-editing tool, CRISPR-Cas9.
Researchers who’ve created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
PetaSuite Cloud Edition genomic data compression software brings PetaGene its second, “Best of Show” award at Bio-IT World.
A team of researchers has unveiled a novel statistical algorithm, capable of identifying potential disease genes in a more accurate and cost-effective way.